Development of a Risk Classifier to Predict Tumor Recurrence and Lenvatinib Benefits in HCC after Liver Transplantation

Yinan Deng(South China Agricultural University), Yang Yang(Sun Yat-sen University)
Research Square
May 31, 2022
Cited by 0


Related Papers

No related papers found

Powered by citation graph analysis